CAR-based cellular therapy for refractory systemic lupus erythematosus: an overlap-controlled systematic review
ObjectivesTo define the current evidence for CAR-based cellular therapy in relapsed or refractory systemic lupus erythematosus (SLE) by resolving overlapping reports and synthesising patient-level phenotype, safety and efficacy data. The primary purpos…